Unknown

Dataset Information

0

Learning oncogenetic networks by reducing to mixed integer linear programming.


ABSTRACT: Cancer can be a result of accumulation of different types of genetic mutations such as copy number aberrations. The data from tumors are cross-sectional and do not contain the temporal order of the genetic events. Finding the order in which the genetic events have occurred and progression pathways are of vital importance in understanding the disease. In order to model cancer progression, we propose Progression Networks, a special case of Bayesian networks, that are tailored to model disease progression. Progression networks have similarities with Conjunctive Bayesian Networks (CBNs) [1],a variation of Bayesian networks also proposed for modeling disease progression. We also describe a learning algorithm for learning Bayesian networks in general and progression networks in particular. We reduce the hard problem of learning the Bayesian and progression networks to Mixed Integer Linear Programming (MILP). MILP is a Non-deterministic Polynomial-time complete (NP-complete) problem for which very good heuristics exists. We tested our algorithm on synthetic and real cytogenetic data from renal cell carcinoma. We also compared our learned progression networks with the networks proposed in earlier publications. The software is available on the website https://bitbucket.org/farahani/diprog.

SUBMITTER: Shahrabi Farahani H 

PROVIDER: S-EPMC3683041 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Learning oncogenetic networks by reducing to mixed integer linear programming.

Shahrabi Farahani Hossein H   Lagergren Jens J  

PloS one 20130614 6


Cancer can be a result of accumulation of different types of genetic mutations such as copy number aberrations. The data from tumors are cross-sectional and do not contain the temporal order of the genetic events. Finding the order in which the genetic events have occurred and progression pathways are of vital importance in understanding the disease. In order to model cancer progression, we propose Progression Networks, a special case of Bayesian networks, that are tailored to model disease prog  ...[more]

Similar Datasets

| S-EPMC4016706 | biostudies-literature
| S-EPMC4889924 | biostudies-literature
| S-EPMC8599758 | biostudies-literature
| S-EPMC6156097 | biostudies-literature
| S-EPMC7671827 | biostudies-literature
| S-EPMC3315310 | biostudies-literature
| S-EPMC2396433 | biostudies-literature
| S-EPMC10271084 | biostudies-literature
| S-EPMC6573476 | biostudies-literature
| S-EPMC6906390 | biostudies-literature